Dmitri Simberg, Ph.D. CURRICULUM VITAE

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Dmitri Simberg, Ph.D. CURRICULUM VITAE"

Transcription

1 Dmitri Simberg, Ph.D. CURRICULUM VITAE A. Education Ph. D. in Biochemistry, The Hebrew University of Jerusalem, Israel. Thesis: Cationic lipid-mediated transfection in vitro and in vivo: the main obstacles and means to overcome them B. Pharm., The Hebrew University of Jerusalem, Israel nd Medical Institute, Moscow, Russian Federation B. Employment History 2013 Assistant Professor, Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy, UC Denver 2013 Associate Project Scientist, UCSD Assistant project scientist, NanoTumor Center, Moores Cancer Center, UCSD Postdoctoral fellow, Laboratory of Prof. Robert Mattrey, Department of Radiology, UCSD. Research Theme: Perfluorocarbon-based molecular imaging reagents Postdoctoral fellow, Laboratory of Prof. Erkki Ruoslahti, Burnham Institute, La Jolla. Research Theme: Amplified targeting of nanoparticles for tumor imaging and treatment Teaching assistant, Hebrew University of Jerusalem C. Grants NIH R33: High quality CTC isolation using microbubbles for subcontract downstream molecular analysis NIH R21 Photoassisted targeting of immunotherapy to the bladder NIH R21 Non invasive detection of DNA biomarkers in pancreatic cancer DoD (Army) breast cancer IDEA Engineered erythrocytes for prevention of metastatic dissemination of breast cancer NIH R21 IMAT Program Isolation of CTCs from blood using microbubbles UCSD ICMIC Developmental Award Ultrasound-Targeted Gene Delivery in B-Cell Malignancies. 1

2 D. Awards 2012 Nano Drug Delivery Symposium Best Poster (3 rd place) Award th International Drug Delivery Symposium s Best Poster Award, Salt Lake City, Utah 2007 Contrast Media Research Young Investigator Award, Banff, Canada Hebrew University Rector s Excellence Scholarship for graduate students th Liposome Research Days conference s Best Poster Award, Berlin, Germany E. Service 2013 Reviewer, NIH Special Emphasis Study Section 2013 Reviewer, The Kentucky Science and Engineering Foundation (KSEF) 2013 Reviewer, The University of Missouri Research Board 2012 Member, Cancer Center Solid Tumor Therapeutics Program 2012 Reviewer, ACS seed grant committee 2013 Scientific Advisor Committee for the Journal of Pharmaceutical Sciences F. Peer reviewed publications In review/revision 1. Shi G, Mukthavaram R, Kesari S, Simberg D. Targeting and Depletion of Circulating Cells and Tumor Cells in Vivo Using Ligand-Painted Erythrocytes (Submitted). 2. Ortac I, Simberg D, Yang J, Trogler WC, Tsien RY, Esener S. Active enzyme loaded nano-wiffle-balls that avoid immune response and proteolysis (Submitted) 3. Miao-Ping Chien, Dmitri Simberg, Matthew P. Thompson, Tomoko Hayashi, Christine Gray, and Nathan C. Gianneschi. Programming Pharmacokinetics in Vivo via Remotely Controlled Switching of Nanoparticle Size and Shape (Second revision). Published 1. Shi G, Cui W, Mukthavaram R, Kesari S, Simberg D. (2013) Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles. Methods (In press). 2. Mukthavaram R, Jiang P, Saklecha R, Bharati I, Nomura N, Chao Y, Pastorino S, Pingle SC, Fogal V, Wrasidlo W, Majeti B, Simberg D, Makale M, Kesari S. (2013) Liposomal encapsulation of staurosporine reduces in vivo toxicity and enhances tumor response. Intl J of Nanomedicine (in press). 3. Shi G, Mukthavaram R, Kesari S, Simberg D. (2013) Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo. Adv. Healthcare Mater (In press). 2

3 4. Chao Y, Karmali P, Mukthavaram R, Kesari S, Kouznetsova V, Tsigelny I, Simberg D. (2013). Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. ACS Nano (in press). 5. Shi, G., Cui, W., Benchimol, M., Liu, Y.-T., Mattrey, R., Kesari, S., Esener, S.C., and Simberg, D. (2013). Isolation of rare tumor cells from blood cells with buoyant perfluorocarbon immuno-microbubbles. PLoS One (in press). 6. Chao Y, Makale M, Karmali P, Tsigelny I, Merkulov S, Ruoslahti E, Simberg D. Recognition of dextran-coated superparamagnetic iron oxide nanoparticles (Feridex) by charged domains of macrophage scavenger receptors. Bioconjugate Chemistry, 2012, 23 (5), Karmali P, Chao Y, Park J-H, Sailor M, Ruoslahti E, Esener S, Simberg D. Different effect of hydrogelation on anti-fouling and circulation properties of iron oxide nanoparticles. Mol Pharmaceutics, 2012, 9 (3), pp Karmali P, Chao Y, Merkulov S, Ruoslahti E, Simberg D. Role of carbohydrate (lectin) receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles. Adv Exp Med Biol. 2012;733: Ibsen S, Benchimol M, Simberg D, Esener S. Ultrasound mediated localized drug delivery. Adv Exp Med Biol. 2012;733: Ibsen S, Benchimol M, Simberg D, Steiner J, Esener S. A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J. Control Release 2011: 155(3): Simberg D, Zhang WM, Merkulov S, McCrae K, Park JH, Sailor MJ, Ruoslahti E. Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. J Control Release 2009: 140, Simberg D, Mattrey, R. Targeting of DNA-coated perfluorocarbon microbubbles to selective populations of circulating blood cells. J. Drug Targeting 2009: 17(5): Simberg D, Park JH, Karmali PP, Zhang WM, Merkulov S, McCrae K, Sailor, MJ, Ruoslahti E. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 2009;30: Park Ji-Ho, von Maltzahn G., Zhang L, Derfus A, Simberg D, Harris T, Bhatia S, Ruoslahti E, Sailor MJ. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 2009, 5(6): Simberg D, Duza T, Park J, Essler M, Pilch J, Zhang L, Derfus AM, Yang M, Hoffman RM, Bhatia S, Sailor MJ, Ruoslahti E. Self-amplifying homing of nanoparticles to tumors. PNAS 2007, 104(3): Khazanov E, Simberg D (equal contribution), Barenholz Y. Lipoplexes prepared from cationic liposomes and mammalian DNA induce CpG-independent, direct cytotoxic effects in cell cultures and in mice. J. Gene Medicine, 2006, 8(8): Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D, Goldwaser I, Barenholz Y, Kedar E. A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice. Vaccine. 2006, 24(18):

4 18. Simberg D, Weiss A, Barenholz Y. Reversible mode of binding of serum proteins to DOTAP/Cholesterol lipoplexes: a possible explanation for intravenous lipofection efficiency. Hum Gene Ther., 2005, 16(9): Simberg D, Weisman S, Talmon Y, Faerman A, Shoshani T, Barenholz Y.The role of organ vascularization and lipoplex serum initial contact in intravenous murine lipofection. J. Biol. Chem., 2003, 278(41): Simberg D, Danino D, Talmon Y, Minsky A, Ferrari M, Wheeler CJ, Barenholz Y. Phase behavior, DNA ordering, and size instability of cationic lipoplexes: relevance to optimal transfection activity. J. Biol. Chem., 2001, 276(50): Simberg D, Hirsch-Lerner D, Nissim R, Barenholz Y. Comparison of different commercially available, cationic lipid-based transfection kits. J. Liposome Res., 2000, 2000, 10: E. Invited book chapters and reviews 1. Simberg D and Tsigelny I. Has the time for in silico design of nanomedicines finally arrived? Editorial in Nanomedicine and Biotherapeutic Discovery. 2. Karmali, PP. and Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opinion Drug Delivery (3): Invited review. 3. Simberg D, Weisman S, Talmon Y, Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Critical Reviews Therapeutic Drug Carrier Syst., 2004, 21(4): Invited review. 4. Simberg D, Hirsch-Lerner D, Zuidam N-J, Even-Chen S, Kerner M, Eliyahu H, Plis- Finarov A, Servel N, Weisman S, Talmon Y, Barenholz Y. Cationic lipid nucleic acid complexes (lipoplexes): from physicochemical properties to in vitro and in vivo transfection kits. NATO ASI Life Sciences, 2003, Chemical Probes in Biology. Book chapter. G. Posters and talks , Long-circulating targeted RBC platform for tumor therapy 2 nd Nanomedicine conference, Los Angeles (poster) , Mechanisms of recognition of iron oxide nanoparticles by macrophage scavenger receptors NanoDDS 12 Atlantic City (poster); , Development of engineered red blood cells as platform for tumor imaging and therapy, Gordon Research Conference, Waterville Valley NH (poster) , Isolation of circulating tumor cells with microbubbles, 11 th Annual Innovative Molecular Analysis Technologies (IMAT) meeting, Rockville, MS (oral presentation) , Engineered erythrocytes for prevention of metastatic cancer, Era of Hope Conference, Orlando (poster); , Mechanisms of immune recognition of nanoparticles, 47 th Oholo Conference, Eilat, Israel (oral presentation); , Mechanisms of Interactions of Iron Oxide Nanoparticles with Proteins and Immune Receptors, TechConnect World, Anaheim (oral presentation); 4

5 , Microbubbles for isolation of tumor biomarkers presented at 10 th Annual Innovative Molecular Analysis Technologies (IMAT) meeting, Bethesda (poster); , Proteomics-assisted study of in vivo clearance of iron oxide nanoparticles presented at 14 th International Drug Delivery Symposium, Salt Lake City (poster); , Interactions between microbubbles and blood cells, presented at Contrast Media Research Conference, Banff, Canada (invited oral presentation); , Self-amplifying delivery of nanoparticles to tumor vasculature, International Conference on Biopharmaceutical Science and Technology, San Diego (invited oral presentation); , Role of serum proteins in the in vivo clearance of iron oxide nanoparticles, 1 st National Cancer Institute Alliance for Nanotechnology in Cancer Investigators Meeting, San Diego (poster); , Mechanisms of binding of serum proteins to cationic lipoplexes, 9 th Liposome Research Days Conference, Hsinchu, Taiwan (poster); , Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity, 8 th Liposome Research Days Conference, Berlin, Germany (poster); , Use of fluorescent probes for studying intracellular fate of cationic lipid-dna complexes, presented at 7 th Conference on Methods and Applications of Fluorescence Amsterdam 2001 (poster); , DNA structure in lipoplexes: effect of lipid composition, 4 th International Conference on Liposome Advances, London (poster); , Oligonucleotide lipoplexes: Electrostatics, state of aggregation and intracellular distribution, NATO ASI workshop, Marathon, Greece (oral presentation). H. Other service (ad hoc reviewer) Angewandte Chemie Intl Edition, International Journal of Nanomedicine; Biomaterials; Journal of Controlled Release; Nanomedicine: Nanotechnology, Biology, and Medicine, Journal of Visualized Experiments, Expert Opinion in Drug Delivery, ACS Nano, Molecular Pharmaceutics, Bioconjugate Chemistry, ACS Applied Materials & Interfaces, Science Transl. Medicine. 5

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy

More information

INNOVATIVE TECHNOLOGY IN MEDICINE: EXPERIENCE OF POLAND AND UKRAINE

INNOVATIVE TECHNOLOGY IN MEDICINE: EXPERIENCE OF POLAND AND UKRAINE LUBLIN SCIENCE AND TECHNOLOGY PARK S.A. International research and practice conference INNOVATIVE TECHNOLOGY IN MEDICINE: EXPERIENCE OF POLAND AND UKRAINE April 28 29, 2017 Lublin, Republic of Poland 2017

More information

Molecules and Particles as Nano- and Micro-scale Drug Carriers

Molecules and Particles as Nano- and Micro-scale Drug Carriers Molecules and Particles as Nano- and Micro-scale Drug Carriers Last time: molecular switches Molecular railways Proteins as motors in nanodevices Today: nano- and micro-particle drug carriers Reading:

More information

Comparison of Commercial Transfection Reagents: Cell line optimized transfection kits for in vitro cancer research.

Comparison of Commercial Transfection Reagents: Cell line optimized transfection kits for in vitro cancer research. Comparison of Commercial Transfection Reagents: Cell line optimized transfection kits for in vitro cancer research. by Altogen Labs, 11200 Manchaca Road, Suite 203 Austin TX 78748 USA Tel. (512) 433-6177

More information

DNA delivery and DNA Vaccines

DNA delivery and DNA Vaccines DNA delivery and DNA Vaccines Last Time: Today: Reading: intracellular drug delivery: enhancing cross priming for vaccines DNA vaccination D.W. Pack, A.S. Hoffman, S. Pun, and P.S. Stayton, Design and

More information

a) JOURNAL OF BIOLOGICAL CHEMISTRY b) PNAS c) NATURE

a) JOURNAL OF BIOLOGICAL CHEMISTRY b) PNAS c) NATURE a) JOURNAL OF BIOLOGICAL CHEMISTRY b) c) d) ........................ JOURNAL OF BIOLOGICAL CHEMISTRY MOLECULAR PHARMACOLOGY TRENDS IN PHARMACOLOGICAL S AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY

More information

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career Post-Baccalaureate Program in Pharmaceutical Science Accelerate your career pharmsci.uci.edu pharmsci-grad@uci.edu 949.824.1991 Improve your career options The Post-Baccalaureate Program in Pharmaceutical

More information

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management Nanotechnology: A Brief History and Its Convergence with Medicine Weston Daniel, PhD Director of Program Management Outline Introduction The Nanoscale Applications Realization of a Vision There s Plenty

More information

Jason A. Stewart. Ph.D. in Biochemistry 2009 University of Rochester, Rochester, NY. B.S. in Microbiology 2003 Brigham Young University, Provo, UT

Jason A. Stewart. Ph.D. in Biochemistry 2009 University of Rochester, Rochester, NY. B.S. in Microbiology 2003 Brigham Young University, Provo, UT Jason A. Stewart University of South Carolina Department of Biological Sciences 715 Sumter Street Columbia, SC 29208 Office Phone: 803.777.9311 Lab Phone: 803.777.4767 Email: jason.stewart@sc.edu Website:

More information

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

SureSilencing sirna Array Technology Overview

SureSilencing sirna Array Technology Overview SureSilencing sirna Array Technology Overview Pathway-Focused sirna-based RNA Interference Topics to be Covered Who is SuperArray? Brief Introduction to RNA Interference Challenges Facing RNA Interference

More information

Intracellular drug delivery: aiding cross presentation of subunit vaccines

Intracellular drug delivery: aiding cross presentation of subunit vaccines Intracellular drug delivery: aiding cross presentation of subunit vaccines Last Time: Today: Reading: basic vaccine concepts Using synthetic biomaterials to enhance cytosolic delivery of molecules Wang

More information

sirna Overview and Technical Tips

sirna Overview and Technical Tips 1 sirna Overview and Technical Tips 2 CONTENTS 3 4 5 7 8 10 11 13 14 18 19 20 21 Introduction Applications How Does It Work? Handy Tips Troubleshooting Conclusions Further References Contact Us 3 INTRODUCTION

More information

Megan P. O Connor, Ph.D.

Megan P. O Connor, Ph.D. Megan P. O Connor, Ph.D. [email] megan.oconnor@yale.edu [phone] +1 518 534 0562 Education and Work Experience Nth Cycle LLC, Guilford, CT, USA Chief Executive Officer September 2017 Present Yale University,

More information

How do drugs work? Part 1. PK: Principles & Processes. PK vs. PD. Pharmacokinetics : Basic Principles Overview. What does the body do to a drug?

How do drugs work? Part 1. PK: Principles & Processes. PK vs. PD. Pharmacokinetics : Basic Principles Overview. What does the body do to a drug? Pharmacokinetics : Basic Principles verview 1. PK : Basic principles and processes 2. Important PK Parameters 3. Modulating PK Parameters 4. PK : Drugs vs. contrast agents Twan Lammers Dept. of Experimental

More information

Leading The Way in Life Science Technologies. Planning Calendar

Leading The Way in Life Science Technologies. Planning Calendar Leading The Way in Life Science Technologies 2018 Planning Calendar January 1 Reservation: 11/30/17 Material: 12/7/17 l Kinase Assays l Immunotherapy l Stem-Cell Manufacturing Peptalk, January 8 12, San

More information

Chinese Pharmaceutical Association

Chinese Pharmaceutical Association Chinese Pharmaceutical Association CPA[2012]No.22 2012 Chinese Pharmaceutical Conference The 1 st Round Conference Announcement Nanotechnology is a cutting edge technology with strategic importance in

More information

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues Dr. René Thürmer BfArM - and dmedical ldevices AGAH Workshop on Liposomal Formulations Bonn / 21.

More information

ZHIQIANG CAO. Wayne State University Assistant Professor, Department of Chemical Engineering and Materials Science, 1/2013- present.

ZHIQIANG CAO. Wayne State University Assistant Professor, Department of Chemical Engineering and Materials Science, 1/2013- present. ZHIQIANG CAO Department of Chemical Engineering and Materials Science Wayne State University 5050 Anthony Wayne Drive, ENG 1123, Detroit, MI 48202 Office: 313-577-3121; Fax: 313-577-3810 Email: zcao@wayne.edu

More information

Ph.D Chemical Engineering, The University of Texas at Austin. B.S Chemical Engineering, University of Minnesota, Minneapolis-St.

Ph.D Chemical Engineering, The University of Texas at Austin. B.S Chemical Engineering, University of Minnesota, Minneapolis-St. Patrick S. Daugherty, Ph.D. Department of Chemical Engineering University of California, Santa Barbara, CA, 93106 Ph: 805-893-2610, Email: psd@engineering.ucsb.edu Education Ph.D. 1999 Chemical Engineering,

More information

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST

Peptide libraries: applications, design options and considerations. Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Peptide libraries: applications, design options and considerations Laura Geuss, PhD May 5, 2015, 2:00-3:00 pm EST Overview 1 2 3 4 5 Introduction Peptide library basics Peptide library design considerations

More information

Biology (BIOL) Biology BIOL 1620

Biology (BIOL) Biology BIOL 1620 (BIOL) BIOL 1010 General Biology, Summer Introduces major themes and concepts of biology including cell and molecular biology, genetics, diversity, evolution, and ecology. Provides students with necessary

More information

Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal

Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal PhD Programme in Medicines and Pharmaceutical Innovation Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal Organizing committee at imed.ulisboa/ffulisboa

More information

EFFICIENCY OF TRANSFECTION 22. May 2017 Bayerische Patentallianz LMU Joseph Rosenecker

EFFICIENCY OF TRANSFECTION 22. May 2017 Bayerische Patentallianz LMU Joseph Rosenecker CLICK PEPTIDIC TO COMPOUND EDIT MASTER FOR IMPROVING TITLE STYLE EFFICIENCY OF TRANSFECTION 22. May 2017 Bayerische Patentallianz LMU Joseph Rosenecker Dr. von Haunersches Kinderspital Ludwig-Maximilians-Universtität

More information

Bioengineering Research in Chemical Engineering

Bioengineering Research in Chemical Engineering BE.010 Spring 2005 Session #8 notes Bioengineering Research in Chemical Engineering Outline of this session: - definition of Chemical Engineering (ChE) and an overview of its undergraduate requirements

More information

Sangtae Kim. Dissertation: Generating Functions of Tandem Mass Spectra and Their Applications to Peptide Identifications Advisor: Pavel Pevzner

Sangtae Kim. Dissertation: Generating Functions of Tandem Mass Spectra and Their Applications to Peptide Identifications Advisor: Pavel Pevzner Sangtae Kim and Engineering 9500 Gilman Drive, La Jolla, CA sak008@ucsd.edu Tel: (858) 525-5284 http://cseweb.ucsd.edu/~sak008 Education Ph.D. in Computer Science Sep. 2006 May 2012 Dissertation: Generating

More information

Chemistry-Biology Interface Training Program

Chemistry-Biology Interface Training Program ChemistryBiology Interface Training Program University of Massachusetts Amherst Biochemistry & Molecular Biology Chemistry Polymer cience & Engineering Chemical Engineering Veterinary & Animal ciences

More information

Convoy TM Transfection Reagent

Convoy TM Transfection Reagent Convoy TM Transfection Reagent Catalog No.11103 0.25ml (40-80 transfections in 35mm dishes) Catalog No.11105 0.5 ml (80-165 transfections in 35mm dishes) Catalog No.11110 1.0 ml (165-330 transfections

More information

Graduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description:

Graduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description: The following is a listing of courses offered by the Graduate Program in Pharmaceutical Science. Prerequisites and brief descriptions are included for each course. For more information on a particular

More information

NanoHealth Enterprise Initiative Engineered Nanomaterials Research and Training

NanoHealth Enterprise Initiative Engineered Nanomaterials Research and Training NanoHealth Enterprise Initiative Engineered Nanomaterials Research and Training Executive Summary The properties that emerge at the nanoscale size, surface-area-to-mass ratio, shape, crystal structure,

More information

New Programs in Quantitative Biology: Hunter College.

New Programs in Quantitative Biology: Hunter College. New Programs in Quantitative Biology: QuBi @ Hunter College What is QuBi? Quantitative Biology An initiative to join computational and quantitative disciplines to the analysis of biological data. Bioinformatics,

More information

Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products

Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products Table of contents 1.Introduction...2 2.Scope...3 3.Discussion...4 3.1. Chemistry, manufacturing, and controls...4

More information

Self-assembling Nanomedicine for Oncology

Self-assembling Nanomedicine for Oncology Self-assembling Nanomedicine for Oncology L. Harivardhan Reddy Pharmaceutical Sciences Department Sanofi-Aventis Research & Development EU-US FOE Symposium 2010, Cambridge 1-3 Sept 2010 List of contents

More information

A unique Collaborative Model for the Discovery of New Therapeutic Approaches

A unique Collaborative Model for the Discovery of New Therapeutic Approaches A unique Collaborative Model for the Discovery of New Therapeutic Approaches THE INNOVATION GAP OPEN INNOVATION TO ADDRESS THE LACK OF PRODUCTIVITY OF BIOPHARMACEUTICAL RESEARCH A PRE-COMPETITIVE PHARMA

More information

Preclinical to Clinical Translation of Antibody Drug Conjugates

Preclinical to Clinical Translation of Antibody Drug Conjugates Preclinical to Clinical Translation of Antibody Drug Conjugates Robert Lutz, PhD Crescendo Biopharma Consulting World ADC Summit Berlin 2016 1 Bio ImmunoGen 23 years Researcher in cell death and survival

More information

SPIE NTU Student Chapter activities

SPIE NTU Student Chapter activities SPIE NTU Student Chapter activities Names and affiliations of current officers: President, Yuan Hsing Fu, yhfu@phys.ntu.edu.tw Vice-President, Tai Chi Chu, d91222023@ntu.edu.tw Secretary, Hung Ji Huang,

More information

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects

More information

PROGRAM Saturday, October 15, 2011 (Officer s Club) Page

PROGRAM Saturday, October 15, 2011 (Officer s Club) Page PROGRAM Saturday, October 15, 2011 (Officer s Club) Page 8:00-8:50 AM Registration/Poster Mounting 8:50-9:00 AM Introductory Remarks Thomas Parks Vice President for Research, University of Utah, USA Chris

More information

参考資料. Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products. Draft

参考資料. Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products. Draft 参考資料 1 2 3 4 5 Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products Draft 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Table of contents 1.

More information

Supporting information. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo

Supporting information. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo Supporting information Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo Greg Thurber 1, Katy Yang 1, Thomas Reiner 1, Rainer Kohler 1, Peter Sorger 2, Tim Mitchison

More information

PLGA Nanoparticles. Production and In Situ Drug Loading Using the NanoAssemblr Benchtop Instrument and the Impact of Solvent Removal Methods.

PLGA Nanoparticles. Production and In Situ Drug Loading Using the NanoAssemblr Benchtop Instrument and the Impact of Solvent Removal Methods. Create Transformative Medicines TM PLGA Nanoparticles Production and In Situ Drug Loading Using the NanoAssemblr Benchtop Instrument and the Impact of Solvent Removal Methods. S.M. Garg, A. Thomas, G.

More information

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD.

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD. Horizon 2020 funding opportunities for Regenerative Medicine (2018-2020) Rudolf Fryček, PhD. Disclaimer: Any information mentioned is preliminary only, always consult the official documents. 1 Outline

More information

Discoveries at the Nano/Bio interface as the impetus to innovation in Nano Safety and Nano Therapeutics

Discoveries at the Nano/Bio interface as the impetus to innovation in Nano Safety and Nano Therapeutics Discoveries at the Nano/Bio interface as the impetus to innovation in Nano Safety and Nano Therapeutics André Nel M.B.,Ch.B; Ph.D Professor of Medicine and Chief of the Division of NanoMedicine at UCLA

More information

EDUCATION TEACHING CERTIFICATES POSITIONS AND EMPLOYMENT

EDUCATION TEACHING CERTIFICATES POSITIONS AND EMPLOYMENT Piyush K. Jain, Ph.D. Massachusetts Institute of Technology, 77 Massachusetts Ave., 76-453, Cambridge, MA, 02139 USA Contact: (816) 522-1229, piyushj@mit.edu, Website: https://piyushjain.mit.edu EDUCATION

More information

TECHNICAL NOTE Phosphorylation Site Specific Aptamers for Cancer Biomarker Peptide Enrichment and Detection in Mass Spectrometry Based Proteomics

TECHNICAL NOTE Phosphorylation Site Specific Aptamers for Cancer Biomarker Peptide Enrichment and Detection in Mass Spectrometry Based Proteomics TECHNICAL NOTE Phosphorylation Site Specific Aptamers for Cancer Biomarker Peptide Enrichment and Detection in Mass Spectrometry Based Proteomics INTRODUCTION The development of renewable capture reagents

More information

leading the way in research & development

leading the way in research & development leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and

More information

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic

More information

Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products

Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products 1 2 3 17 January 2013 EMA/CHMP/13099/2013 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Joint MHLW/EMA reflection paper on the development of block copolymer micelle Agreed by Nanomedicines

More information

Strategy for Selecting NAb Assay Format

Strategy for Selecting NAb Assay Format Strategy for Selecting NAb Assay Format European Bioanalysis Forum 27Sept2016 Jim McNally, Ph.D. Associate Director, Global Early Development Head of Clinical Bioanalytics Merck KGaA AAPS Working Group

More information

Konica Minolta to Acquire Invicro (US)

Konica Minolta to Acquire Invicro (US) Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September

More information

Nanotechnology and Advanced Materials for more effective Healthcare

Nanotechnology and Advanced Materials for more effective Healthcare Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics

More information

CURRICULUM VITAE. Lecturer (Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al- Azhar University, Cairo, Egypt)

CURRICULUM VITAE. Lecturer (Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al- Azhar University, Cairo, Egypt) CURRICULUM VITAE Farag F. S. Selim, PhD CONTACT DETAILS Name: Farag Farouk Sherbiny Selim Nationality: Egyptian Position: Lecturer (Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al- Azhar University,

More information

S3 Table. Research topics in molecular biology.

S3 Table. Research topics in molecular biology. S3 Table. Research topics in molecular biology. B0 cell express activ signal develop Development, Molecular and Cellular Biology, Cancer Research, Genes & Development, Journal of Immunology B1 patient

More information

Application of RNA Interference to Anti-Doping. Matthew Fedoruk, Ph.D. Gene & Cell Doping Symposium 2013, Beijing, China

Application of RNA Interference to Anti-Doping. Matthew Fedoruk, Ph.D. Gene & Cell Doping Symposium 2013, Beijing, China Application of RNA Interference to Anti-Doping Matthew Fedoruk, Ph.D. Gene & Cell Doping Symposium 2013, Beijing, China From Plants to Worms to Humans: Discovery and Mechanism of RNAi Alnylam Pharmaceuticals

More information

The Application of DNA Nanotechnology for Guided Drug Delivery

The Application of DNA Nanotechnology for Guided Drug Delivery Tony Wang Professor Scarlatos HON 301 October 19th, 2014 Introduction: The Application of DNA Nanotechnology for Guided Drug Delivery A major problem that exists in drug-based disease treatments is the

More information

Baek, Kyung-min. Recombinant Protein Products Division. Ministry of Food and Drug Safety

Baek, Kyung-min. Recombinant Protein Products Division. Ministry of Food and Drug Safety Baek, Kyung-min Recombinant Protein Products Division Ministry of Food and Drug Safety About Ministry of Food and Drug Safety Regulation for Biosimilar Principle of Biosimilar Approach Status of Biosimilar

More information

Europass Curriculum Vitae

Europass Curriculum Vitae Europass Curriculum Vitae Personal information Surname / First name Dal Collo Giada 7, Via Canova, 36010, Velo d Astico (VI), Address Italy Mobile +39 3481525172 E-mail giada.dalcollo@gmail.com Nationality

More information

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch,

High Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch, High Profile Publishing in Molecular Biology Hélène Hodak, h.hodak@elsevier.com Marina Ostankovitch, m.ostankovitch@elsevier.com The field of Molecular Biology, inception to current trends Preparing a

More information

Biomedical Applications of Molecular Spectroscopy

Biomedical Applications of Molecular Spectroscopy Biomedical Applications of Molecular Spectroscopy Mike Kayat B&W Tek, Inc 19 Shea Way Newark, DE 19713 United States of America +1 302 368 7824 mikek@bwtek.com 1 Overview Molecular spectroscopy is a large

More information

Prof. Dr. Dr. Karl Siegfried Boos. 18 th September th October 2014

Prof. Dr. Dr. Karl Siegfried Boos. 18 th September th October 2014 Prof. Dr. Dr. Karl Siegfried Boos 18 th September 1948 6 th October 2014 Curriculum vitae Karl Siegfried Boos was born on the 18 th September 1948 in Rastatt/Baden, Germany. He studied biochemistry at

More information

Identification of Critical Product Quality Attributes: Impact of Product Variants on Safety and Efficacy

Identification of Critical Product Quality Attributes: Impact of Product Variants on Safety and Efficacy Identification of Critical Product Quality Attributes: Impact of Product Variants on Safety and Efficacy Ziping Wei, Ph.D. Analytical Biochemistry MedImmune January 25, 2010 Outline Why do we need to identify

More information

Small Interfering RNA s Molecular biology and use in therapy

Small Interfering RNA s Molecular biology and use in therapy Small Interfering RNA s Molecular biology and use in therapy Dr Stuart Hamilton - NHMRC Early Career Fellow Serology and Virology Division, SEALS Microbiology, Prince of Wales Hospital; School of Women

More information

Nanomedicine and NanoDiagnostics: Innovation, Regulation, and Investment

Nanomedicine and NanoDiagnostics: Innovation, Regulation, and Investment Nanomedicine and NanoDiagnostics: Innovation, Regulation, and Investment Mostafa Analoui, PhD Head of Healthcare and Life Sciences The Livingston Group, New York, NY Nano-Manufacturing Summit 2011, and

More information

Microbiology and Molecular Genetics

Microbiology and Molecular Genetics University of California, Irvine 2017-2018 1 Microbiology and Molecular Genetics Rozanne M. Sandri-Goldin, Department Chair Klemens J. Hertel, Department Vice Chair Klemens J. Hertel, Departmental Graduate

More information

Introduction to Assay Development

Introduction to Assay Development Introduction to Assay Development A poorly designed assay can derail a drug discovery program before it gets off the ground. While traditional bench-top assays are suitable for basic research and target

More information

Artificial Nucleic Acids -Their Developments and Recent Applications

Artificial Nucleic Acids -Their Developments and Recent Applications Artificial Nucleic Acids -Their Developments and Recent Applications Bioorganic Chemistry Laboratory D2 Kenichiro Ito Organic Seminar 2012/5/7 1 Nucleic acids play central roles in life Replication Transcription

More information

Biopharmaceuticals - Current FDA & EMAs Regulations on glycan analysis

Biopharmaceuticals - Current FDA & EMAs Regulations on glycan analysis Biopharmaceuticals - Current FDA & EMAs Regulations on glycan analysis Jayesh Kattla, PhD March 2015 Gothenburg & Copenhagen 2013 Waters Corporation 1 Hope and Risk 2013 Waters Corporation 2 The total

More information

BL-7040: Oligonucleotide for Inflammatory Bowel Disease

BL-7040: Oligonucleotide for Inflammatory Bowel Disease BL-7040: Oligonucleotide for Inflammatory Bowel Disease December 2012 Forward Looking Statements This presentation contains "forward-looking statements." These statements include words like "may," "expects,"

More information

UCSD Year 1 Participants in the Nanomedicine Training Program (CRIN R25T)

UCSD Year 1 Participants in the Nanomedicine Training Program (CRIN R25T) UCSD Year 1 Participants in the Nanomedicine Training Program (CRIN R25T) Graduate Students Michael Benchimol Electrical Eng (ECE) Mentors Esener PhD (NanoE) and Reid MD (Medicine) Csilla Felsen - MSTP

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

The Promise of DARPins for Site-Specific Drug Conjugation & Pharmacokinetic Optimization

The Promise of DARPins for Site-Specific Drug Conjugation & Pharmacokinetic Optimization Department of Biochemistry The Promise of DARPins for Site-Specific Drug Conjugation & Pharmacokinetic Optimization Fabian Brandl, Plückthun Group, University of Zurich / University of Bern World ADC Berlin,

More information

KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar

KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar Kyung-Min Baek, Ph.D. Recombinant Protein Products Division Korea Food and Drug Administration(KFDA) Biopharmaceuticals A biopharmaceutical

More information

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome

More information

Assays for Immunogenicity: Are We There Yet?

Assays for Immunogenicity: Are We There Yet? Assays for Immunogenicity: Are We There Yet? Mark Wener, MD Department of Laboratory Medicine & Rheumatology Division Department of Medicine University of Washington Seattle, WA 98195 wener@uw.edu Goals:

More information

ZHOU, CAIZHI EDUCATION RESEARCH INTERESTS EXPERIENCE

ZHOU, CAIZHI EDUCATION RESEARCH INTERESTS EXPERIENCE ZHOU, CAIZHI Couch Assistant Professor of Materials Science & Engineering Department of Materials Science and Engineering Missouri University of Science and Technology B37 McNutt Hall, Rolla, MO 65409-0340

More information

Gene-silencing oligonucleotides: Innovative design of oligonucleotides with enhanced efficacy and RNAilike mechanism of action

Gene-silencing oligonucleotides: Innovative design of oligonucleotides with enhanced efficacy and RNAilike mechanism of action Gene-silencing oligonucleotides: Innovative design of oligonucleotides with enhanced efficacy and RNAilike mechanism of action Nicola La Monica, Ekambar R. Kandimalla, Sudhir Agrawal Idera Pharmaceuticals,

More information

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date F o r a c l e a r e r m a r k e t p e r s p e c t i v e Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y Report

More information

NANO TECHNOLOGY AND MATERIAL SCIENCE EXPO Propel New Technologies by Integrating Nanoscience and Material structures

NANO TECHNOLOGY AND MATERIAL SCIENCE EXPO Propel New Technologies by Integrating Nanoscience and Material structures NANO TECHNOLOGY AND MATERIAL SCIENCE EXPO 2017 Propel New Technologies by Integrating Nanoscience and Material structures DUBAI, December 04-06, 2017 Contact Us nanoscience@linkinscience.com 649 Mission

More information

Advances in Delivery Science and Technology

Advances in Delivery Science and Technology Advances in Delivery Science and Technology Series Editor Michael J. Rathbone More information about this series at http://www.springer.com/series/8875 Kenneth A. Howard Thomas Vorup-Jensen Dan Peer Editors

More information

Nanotoxicology. Some nanomaterial properties raise toxicity concerns. Small size. High surface area. Fibrous morphology

Nanotoxicology. Some nanomaterial properties raise toxicity concerns. Small size. High surface area. Fibrous morphology Nanotoxicology Some nanomaterial properties raise toxicity concerns Small size - small aerodynamic diameter deep lung penetration - high permeability in biological membranes - enhanced cellular uptake

More information

Cytomics in Action: Cytokine Network Cytometry

Cytomics in Action: Cytokine Network Cytometry Cytomics in Action: Cytokine Network Cytometry Jonni S. Moore, Ph.D. Director, Clinical and Research Flow Cytometry and PathBioResource Associate Professor of Pathology & Laboratory Medicine University

More information

DNA Coated Gold Nanoshells for Laser Induced Antisense Drug Release in Cells

DNA Coated Gold Nanoshells for Laser Induced Antisense Drug Release in Cells DNA Coated Gold Nanoshells for Laser Induced Antisense Drug Release in Cells Marcus Rosario Mentor Gary Braun Dr. Norbert Reich National Institutes of Health Ventura College Molecular Biology The Big Picture

More information

Program of study. pharmacy. 1st year

Program of study. pharmacy. 1st year II I Program of study pharmacy 1st year Anatomy 15-15 GC Biophysics 15 15 - E Biology and Genetics 60 15 15 E 4 Botany 90 45 15 E 7 Analytical I 4 1 - E General and Inorganic 105 45 E 7 Latin Course -

More information

Invitation for Conference

Invitation for Conference Invitation for Conference Global Summit and Expo on Current Scenario and Future Stem Cell Medicine Website: http://stemcell.scientificsynergy.com/ Email id: contact@scientificsynergy.com stemcell@scientificsynergy.com

More information

INTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS. Guy Cavet

INTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS. Guy Cavet INTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS Guy Cavet g.cavet@atreca.com PRECISION THERAPIES FROM THE ACTIVE IMMUNE RESPONSE Patient/Animal with Immune Response Immune Repertoire Capture

More information

Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages

Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Introduction It is well accepted that the limitations of antibodies present valuable commercial opportunities for alternative

More information

NOVEL DRUG DELIVERY SYSTEMS II

NOVEL DRUG DELIVERY SYSTEMS II NOVEL DRUG DELIVERY SYSTEMS II Polymer Science 1. Define Polymer. Describe its properties. 2. Classify polymers based on various criteria. 3. What are the ideal characteristics of biodegradable polymers?

More information

Primiano Pio Di Mauro, Biomedical Engineer, PhD in Bioengineering

Primiano Pio Di Mauro, Biomedical Engineer, PhD in Bioengineering Primiano Pio Di Mauro, Biomedical Engineer, PhD in Bioengineering pri.dimauro@gmail.com Mobile: 0034 689326511 Carrer de la Diputació 478 1º2ª, 08013, Barcelona, Spain https://www.linkedin.com/in/pridimauro/

More information

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA ) Area 1.0 Basic Biomedical Sciences (10%) Area 2.0 Pharmaceutical Sciences (33%) Area 3.0 Social/Behavioral/Administrative Sciences (22%)

More information

Preclinical pharmacokinetics and pharmacodynamics of AG-519, an allosteric pyruvate kinase activator

Preclinical pharmacokinetics and pharmacodynamics of AG-519, an allosteric pyruvate kinase activator S830 Preclinical pharmacokinetics and pharmacodynamics of AG-519, an allosteric pyruvate kinase activator Yue Chen, Raj Nagaraja, Kha Le, Penelope A Kosinski, Gavin Histen, Charles Kung, Hyeryun Kim, Chandra

More information

Building a Career in the Pharmaceutical Industry: Personal Reflections. Carlo Nalin, PhD Executive Director Novartis Oncology

Building a Career in the Pharmaceutical Industry: Personal Reflections. Carlo Nalin, PhD Executive Director Novartis Oncology Building a Career in the Pharmaceutical Industry: Personal Reflections Carlo Nalin, PhD Executive Director Novartis Oncology 2 Career Development: Personal Reflections C Nalin 5 April 2016 Cornell BEST

More information

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Department of Biochemistry and Molecular Biology 1 DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY Office in Molecular and Radiological Biosciences Building, Room 111 (970) 491-5602 bmb.colostate.edu

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

DNA Microarray Technology

DNA Microarray Technology CHAPTER 1 DNA Microarray Technology All living organisms are composed of cells. As a functional unit, each cell can make copies of itself, and this process depends on a proper replication of the genetic

More information

Life SCIENCE GR ADUATE SCHOOL OF

Life SCIENCE GR ADUATE SCHOOL OF GR ADUATE SCHOOL OF Life SCIENCE Transdisciplinary Life Science Course Biosystems Science Course Biomedical and Pharmaceutical Science Course Division of Clinical Pharmacy Message from the Dean Masakane

More information

Curriculum Vitae Xinglin Lu

Curriculum Vitae Xinglin Lu Curriculum Vitae Educational Background Ph.D. 2015. Municipal Engineering, Harbin Institute of Technology. Title of Ph.D. Dissertation: "Mechanisms and Control Strategies of Fouling Propensity and Reverse

More information

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA Dr. Henry Daniell Pegasus Professor & University Board of Trustee Chair Dept. Mol.

More information